Entrada Therapeutics logo

Entrada Therapeutics

Entrada Therapeutics is a biologics delivered to cytosol founded in 2016.

2

Funding Rounds

$175.0m

Money raised

Overview

Entrada Therapeutics is a biologics delivered to cytosol founded in 2016.

Funding series

Funding Series Analysis

The company Entrada Therapeutics has raised a total of $116m in funding over 2 rounds.

Key Insights:

  • Entrada Therapeutics, Inc. funding round, April 2021: $116m
  • Entrada Therapeutics funding round, December 2018: $59m
Entrada Therapeutics logo
Entrada Therapeutics, Inc. funding round, April 2021 $116m
Entrada Therapeutics logo
Entrada Therapeutics funding round, December 2018 $59m